Biomedical Engineering Reference
In-Depth Information
β
-Carotene
54
OH
Vitamin A
55
FIGURE 2.1
Carotenoid derivatives.
TMS ZnBr
Pd(PPh
3
)
4
(2 mol%)
THF
81%
Br
TMS
I
Br
56
57
SCHEME 2.19
Preparation of the C4 synthon.
1. LDA
O
2. ClPO(OEt)
2
3. LDA
85%
58
59
1. Me
3
Al, Cp
2
ZrCl
2
, CH
2
Cl
2
2. ZnCl
2
, THF
1.
57
, Pd
2
(dba)
3
(2.5 mol%)
tri(2-furyl)phosphine (10 mol%)
ZnCl
2. K
2
CO
3
, MeOH
70%
61
60
SCHEME 2.20
Synthesis of the tetraenyne.
Tetraenyne
61
, on the other hand, was prepared starting from
b
-ionone
58
,
whichwas first converted to the corresponding terminal alkyne
by elimination of an
enol phosphate intermediately formed (Scheme 2.20). Carboalumination, ZnCl
2
addition, Negishi coupling, and deprotection of the trimethylsilyl group finally
yielded the desired compound
59
.
The carboalumination and transmetalation were performed on synthon
61
61
,
followed by a Negishi coupling with 0.5 equiv of
56
to provide
b
-carotene
54
(Scheme 2.21).
Compound
was also involved in the preparation vitamin A. It was first
subjected to a carboalumination reaction, followed by a metal-metal exchange with
n-
BuLi and a final formylation (Scheme 2.22).
61
1. Me
3
Al, Cp
2
ZrCl
2
, CH
2
Cl
2
2. ZnCl
2
, THF
3.
56
, Pd
2
(dba)
3
(2.5 mol%)
tri(2-furyl)phosphine (10 mol%)
68%
SCHEME 2.21
61
-Carotene
(
54
)
β
Synthesis of
b
-carotene.
Search WWH ::
Custom Search